Epidemiological data on anaemia during malignant affections;Données épidémiologiques sur l'anémie dans les affections malignes

Presse Medicale

Volumn 32, Issue 29, 2003, Pages 1368-1370

  Solignac, M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ANEMIA; CONFERENCE PAPER; HODGKIN DISEASE; HUMAN; INFLAMMATION; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; SOLID TUMOR; SURVIVAL;

EID: 0141483575     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (4)

1. Ludwig H, Birgegärd G, Olmi P, Nortier JW, ECAS (European Cancer Anaemia Survey) Prospective evaluation of anemia in over 15000 cancer patients Ann Oncol 2002; 13 (suppl 5): 169 (abstract 623 PD).
2. Littlewood TJ, Bajetta E, Nortier JW et al. Effects of epoetin alpha on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemiotherapy: results of a randomized, double-blind, placebo-controlled trial J Clin Oncol 2001; 19: 2865-74.
3. Birgegärd G, Ludwig H, Nortier J, Schrijvers D Despite high prevalence of anemia and impact on performance status, anemia treatment rate is low in multiple myeloma/lymphoma patients according to European cancer anaemia survey (ECAS) The Hematology Journal 2003; 4 (suppl 2): abstract 0851.
4. Ahmad I, Meleman N, Bernier M. et al. Prognostic value of anemia in lymphomas varies according to histological subtype and patient age The Hematology Journal 2003; 4 (suppl 2): abstract 0850.